InvestorsHub Logo
icon url

Bed Bath & Beyonce

05/29/17 3:28 PM

#41478 RE: MightyX #41477

Again, Big Pharma's only interest right now is to lobby the hell out of politicians and keep medical marijuana at a distance.

Big Pharma is not going to publicly touch anything that involves marijuana until it's re-scheduled....period.

And when it is re-scheduled, they're not going to take some non-laboratory controlled "data" that is barely two years old, when there is plenty of other laboratory controlled information out there. Do you really think Pfizer is going out its billions and SP at risk on the word of some "data" they have zero way of verifying?

EVERY nano-cap MJ stock has this false speculation. The MJ growing supply companies....OMG, Scott's is going to buy them out. MJ marketing companies, OMG Snoop Dogg is going to be involved. None of that is going to happen until marijuana is re-scheduled. NOTHING.

MYDX's challenge is whether it can keep its head above water until the re-scheduling. And the re-sched couldn't be further off any politician's radar than right now.
icon url

doctoron

05/29/17 3:32 PM

#41480 RE: MightyX #41477

Isn't spectrographic analysis kind of specific? If a substance produces a chemical fingerprint that matches another, say from a different state and verified by a centralized database, wouldn't that lend to conclude that the substances are the same--even if called by different names? Neilson uses similar, crowd data type of sampling to gauge ratings for television. Why is this any different? There is brilliance in getting crowd sourced data and while some may criticize it, no one can deny its correlative integrity.